{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:35:54Z","timestamp":1784025354696,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Migraine is increasingly recognized as a disorder with both neurological and psychiatric dimensions, with increasing evidence suggesting a potential link to psychotic symptoms through shared dopaminergic dysfunction. Both conditions exhibit dopamine receptor hypersensitivity, neurotransmitter imbalances, and altered cortical excitability, raising the question of whether migraineurs, particularly those with aura, may be more susceptible to transient psychotic-like symptoms. This review explores the neurobiological overlap between migraine and psychosis, focusing on shared pathophysiological mechanisms, neuroimaging findings, and clinical evidence. Neuroimaging studies have revealed that migraineurs exhibit altered dopamine receptor binding and reduced synaptic dopamine during attacks, whereas psychotic disorders are characterized by sustained dopaminergic hyperactivity. These observations support the hypothesis that dopaminergic dysregulation may predispose migraineurs to sensory\u2013perceptual disturbances that occasionally resemble psychotic symptoms. Importantly, this overlap does not imply that migraine leads to psychosis but rather suggests that shared neurochemical dysfunction may transiently modulate perception. Future research should clarify this interaction to improve the early identification and management of neuropsychiatric manifestations in migraine patients.<\/jats:p>","DOI":"10.3389\/fneur.2025.1577146","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:11:15Z","timestamp":1746763875000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Bridging migraine and psychosis: a neuropsychiatric review of shared dopaminergic mechanisms"],"prefix":"10.3389","volume":"16","author":[{"given":"Rithin Jacob","family":"Antony Rajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshini","family":"Esther A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/03331024231209303","article-title":"The evolutionary meaning of migraine: from a protective to a maladaptive trait","volume":"24","author":"Pensato","year":"2023","journal-title":"J Headache Pain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/WCO.0b013e3283378d5c","article-title":"Dopamine: what's new in migraine?","volume":"23","author":"Charbit","year":"2010","journal-title":"Curr Opin Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1468-2982.2004.00839.x","article-title":"Psychiatric comorbidity in migraine: a review","volume":"25","author":"Radat","year":"2005","journal-title":"Cephalalgia."},{"key":"B4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jad.2015.02.032","article-title":"A meta-analysis investigating the prevalence and moderators of migraines among people with bipolar disorder","volume":"178","author":"Fornaro","year":"2015","journal-title":"J. Affect. Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10194-019-1066-0","article-title":"Mechanisms of migraine as a chronic evolutive condition","volume":"20","author":"Andreou","year":"2019","journal-title":"J Headache Pain."},{"key":"B6","first-page":"1306","article-title":"Dopamine: What's new in migraine?","volume":"30","author":"Charbit","year":"2010","journal-title":"Cephalalgia."},{"key":"B7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s13311-018-0614-7","article-title":"Targeted nitric oxide synthase inhibitors for migraine","volume":"15","author":"Pradhan","year":"2018","journal-title":"Neurotherapeutics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1468-2982.2007.01478.x","article-title":"Dopamine and migraine: Biology and clinical implications","volume":"27","author":"Akerman","year":"2007","journal-title":"Cephalalgia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1046\/j.1468-2982.1998.1804174.x","article-title":"Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data","volume":"18","author":"Mascia","year":"1998","journal-title":"Cephalalgia."},{"key":"B10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1212\/wnl.49.3.650","article-title":"Dopamine and migraine","volume":"49","author":"Peroutka","year":"1997","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10072-013-1415-8","article-title":"Dopaminergic symptoms in migraine","volume":"34","author":"Barbanti","year":"2013","journal-title":"Neurol Sci."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111557","article-title":"Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine","author":"Khan","year":"","journal-title":"Biomed Pharmacother."},{"key":"B13","doi-asserted-by":"crossref","unstructured":"Genetic aspects in migraine and vestibular migraine\n          \n          513\n          19\n          \n            \n              Murofushi\n              T\n            \n          \n          Equilibrium Res.\n          74\n          2015","DOI":"10.3757\/jser.74.513"},{"key":"B14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2013The final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"B15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am J Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1073\/pnas.97.14.7673","article-title":"Schizophrenia: more dopamine, more D2receptors","volume":"97","author":"Seeman","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat Rev Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1212\/WNL.0000000000003861","article-title":"Dopamine D2\/D3 imbalance during migraine attack and allodynia in vivo","volume":"88","author":"DaSilva","year":"2017","journal-title":"Neurology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0304-3940(96)12491-5","article-title":"Increased density of dopamine D5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine?","volume":"207","author":"Barbanti","year":"1996","journal-title":"Neurosci Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.neubiorev.2009.06.005","article-title":"Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes","volume":"34","author":"Tost","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/schbul\/sbq031","article-title":"Dopaminergic Dysfunction in schizophrenia: salience attribution revisited","volume":"36","author":"Heinz","year":"2010","journal-title":"Schizophr. Bull."},{"key":"B22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/WCO.0b013e3283532ca3","article-title":"Migraine changes the brain","volume":"25","author":"Sprenger","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1173596","article-title":"Classifying migraine using PET compressive big data analytics of brain's \u03bc-opioid and D2\/D3 dopamine neurotransmission","author":"Marino","year":"2023","journal-title":"Front Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210093","article-title":"Excitation-inhibition imbalance in migraine: from neurotransmitters to brain oscillations","author":"O'Hare","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.26717\/BJSTR.2025.60.009412","article-title":"Panax ginseng in migraine management: dopaminergic and neuroprotective effects from preclinical and clinical evidence","author":"Antony","year":"2025","journal-title":"Biomed J Sci Tech Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1177\/0333102420929023","article-title":"Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients","volume":"40","author":"Barbanti","year":"2020","journal-title":"Cephalalgia."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00415-023-12144-9","article-title":"Multisensory hallucinations and other unusual sensory experiences in the context of migraine: a systematic review","volume":"271","author":"Li","year":"2024","journal-title":"J Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.biopsych.2016.03.2105","article-title":"Dopamine and the adolescent brain: do errors in prediction make the difference?","volume":"79","author":"Pauli","year":"2016","journal-title":"Biol Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1129-2377-14-34","article-title":"Prevalence of migraine and co-morbid psychiatric disorders among students of Cumhuriyet University","author":"Semiz","year":"2013","journal-title":"J Headache Pain"},{"key":"B30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/PEC.0000000000000718","article-title":"Relative effectiveness of dopamine antagonists for pediatric migraine in the emergency department","volume":"34","author":"Sheridan","year":"2018","journal-title":"Pediatr Emerg Care."},{"key":"B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11940-011-0150-9","article-title":"Use of dopamine antagonists in treatment of migraine","volume":"14","author":"Marmura","year":"2011","journal-title":"Curr Opin Neurol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107704","article-title":"Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology","author":"Kaar","year":"2020","journal-title":"Neuropharmacology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1577146\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:11:17Z","timestamp":1746763877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1577146\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":33,"alternative-id":["10.3389\/fneur.2025.1577146"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1577146","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"article-number":"1577146"}}